WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma

NCT05678998 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumors
Non-Hodgkin Lymphoma

Interventions

DRUG: WTX-330

Sponsor

Werewolf Therapeutics, Inc.